The strains specificity outweighs the CFU count
Its a targeted indication (VAT reduction in a specific population), not a blank-check fat-loss drug
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide are backed by STEP ( The New England Journal of Medicine , 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024)
We want to make sure that a full assessment is being done, that people are being given good nutritional support, mental health support, and are being examined by a healthcare provider before being given medications
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada
FSP1 converts the ubiquinone on the cell membrane into its reduced form ubiquinol, which can inhibit peroxidation and prevent ferroptosis [50]